Detection of extended spectrum B-lactamases in urinary isolates of Klebsiella pneumoniae in relation to BlaSHV, BlaTEM and BlaCTX-M gene carriage

Iranian Journal of Public Health

Volumn 41, Issue 3, 2012, Pages 127-132

  Eftekhar, F ^a   Rastegar, M ^a   Golalipoor, M ^b   Mansoursamaei, N ^c  

^a SHAHID BEHESHTI UNIVERSITY   (Iran)

^b GOLESTAN UNIVERSITY   (Iran)

^c GOLESTAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Extended spectrum lactamases; Klebsiella pneumoniae; Urinary infection

Indexed keywords

EID: 84858393905     PISSN: 22516085     EISSN: 22516093     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Podschun R, Ullman U (1998). Klebsiella spp. as nosocomial pathogens: epidemiology, taxonomy, typing methods and pathogenicity factors. Clin Microbiol Rev, 11: 589-603.
2. Bradford PA (2001). Extended-spectrum β-lactamases in the 21st century: Characterization, epidmiology and detection of this important resistance threat. Am Soc Microbiol, 14: 933-51.
3. Paterson DL, Bonomo RA (2005). Extendedspectrum ß-lactamases: a clinical update. Clin Microbiol Rev, 18: 657-86.
4. Paterson DL, Hujer KM, Hujer AM, Yeiser B, Bonomo MD, Rice LB, Bonomo RA and the International Klebsiella Study Group (2003). Extended-spectrum ß-lactamases in Klebsiella pneumoniae bloodstream isolates from seven countries: dominance and widespread prevalence of SHV and CTX-M type ß-lactamases. Antimicrob Agents Chemother, 47: 3554-60.
5. Mulvey MR, Bryce E, Boyd D, Ofner-agostini M, Christianson S, Simor A E, Paton S, and the Canadian Hospital Epidemiology Committee, Canadian Nosocomial Infection Surveillance Program, Health Canada (2004). Ambler Class A extended-spectrum β- lactamase-producing Escherichia coli and Klebsiella spp. in Canadian hospitals. Antimicrob Agents Chemother, 48(4): 1204-14.
6. Jacoby GA, Han P (1996). Detection of extended- spectrum β-lactamases in clinical isolates of Klebsiella pneumoniae and Escherichia coli. J Clin Microbiol, 34(4): 908-11.
7. Brun-Buisson C, Legrand P, Philippon A, Montravers F, Ansquer M, Duval J (1987). Transferable enzymatic resistance to thirdgeneration cephalosporins during nosocomial outbreak of multiresistant Klebsiella pneumoniae. Lancet ii, 302-6.
8. Knothe H, Shah P, Kremery V, Antal M, Mitsuhashi S (1983). Transferable resistance to cefotaxime, cefoxitin, cefamandole and cefuroxime in clinical isolates of Klebsiella pneumoniae and Serratia marcescens. Infect, 11: 315-7.
9. Sirot D (1995). Extended spectrum plasmid mediated ß-lactamases. J Antimicrob Chemother, 36 suppl A: 19-34.
10. Jemima SA, Verghese S (2008). Multiplex PCR for bla(CTX-M) and bla(SHV) in the extended spectrum β-lactamase (ESBL) producing Gram-negative isolates. Ind J Med Res, 128(3): 313-7.
11. Stewart CD, Rasheed JK, Hubert SK, Biddle JW, Raney PM, Anderson GJ, Williams PP, Brittain KL, Oliver A, McGowan JE Jr, Tenover FC (2001). Characterization of clinical isolates of Klebsiella pneumoniae from 19 laboratories using the National Committee for Clinical Laboratory Standards Extended-Spectrum ß-lactamase detection methods. J Clin Microbiol, 39(8): 2864-72.
12. Nijssen S, Florijn A, Bonten MJM, Schmitz FJ, Verhoef J, Fluit AC (2004). β-lactam susceptibilities and prevalence of ESBL-producing isolates among more than 5000 European Enterobacteriaceae isolates. Internat J of Antimicrob Agents, 24: 585-91.
13. Reinert RR, Low DE, Rossi F, Zhang X, Wattal C, Dowzicky MJ (2007). Antimicrobial susceptibility among organisms from the Asia/Pacific Rim, Europe and Latin and North America collected as part of test and the in vitro activity of tigecycline. J Antimicrob Agents Chemother, 60(5): 1018-29.
14. Aminzadeh Z, Sadat Kashi M, Sha'bani M (2008). Bacteriuria by extended-spectrum β- lactamase-producing Escherichia coli and Klebsiella pneumoniae isolates in a governmental hospital in south of Tehran, Iran. Iran J Kidney Dis, 2: 197-200.
15. Feizabadi MM, Etemadi G, Yadegarinia D, Rahmati M, Shabanpoor S, Bokaei S (2006). Antibiotic resistance patterns and frequency of extended-spectrum β-lactamase-producing isolates of Klebsiella pneumoniae in Tehran. Med Sci Monitor, 12(11): 362-5.
16. FeizabadIi MM, Farahani AS, Rahmati M, Asadi S (2008). Phenotypic characterization and plasmid analysis of Klebsiella pneumoniae strains from Iranian patients. R. Ci. méd. biol. Salvador, 7(3): 273-9.
17. Irajian G, Jazayeri-Moghadas A, Beheshti A (2009). Prevalence of extended-spectrum β-lactamase positive and multidrug resis tance pattern of Escherichia coli and Klebsiella pneumoniae isolates, Semnan, Iran. Iran J Microbiol, 1: 49-53.
18. Shahcheraghi F, Moezi H, Feizabadi MM (2007). Distribution of TEM and SHV betalactamase genes among Klebsiella pneumoniae strains isolated from patients in Tehran. Med Sci Monitor, 13(11): 247-50.
19. th edition. Approved standard M2-A8, Wayne, Pennsylvania, USA.
20. National Committee for Clinical Laboratory Standards (NCCLS) (2002). Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, Approved Standard M2/A7, Wayne, Pennsylvania, USA.
21. Health Protection Agency, Laboratory detection and reporting of bacteria with extended spectrum β-lactamase (2008), National Standard Method QSOP 51, issue 2.2.
22. Lal P, Kapil A, Das BK, Sood S (2007). Occurrence of TEM & SHV gene in extended spectrum β-lactamases (ESBLs) producing Klebsiella spp. isolated from a tertiary care hospital. Ind J Med Res, 125: 173-8.
23. Tribuddharat C, Srifuengfung S, Chiangjong W (2007). A correlation between phenotypes and genotypes of extended-spectrum betalactamase (ESBL)-producing Klebsiella pneumoniae in a university hospital, Thailand. Dis Antimicrob Agents, 24: 117-23.
24. Jain A, Mondal R (2008). TEM and SHV genes in extended spectrum β-lactamase producing Klebsiella species and their antimicrobial resistance pattern. Ind J Med Res, 128: 759-64.
25. Perilli M, Amico ED, Segatore B, Rosaria de Massis M, Bianchi C, Luzzaro F (2002). Molecular characterization of extendedspectrum β-lactamases produced by nosocomial isolates of Enterobacteriaceae from an Italian Nationwide survey. J Clin Microbiol, 611-4.
26. Brown DFJ, Andrews J, King A, MacGowan AP (2000). Detection of extended-spectrum β-lactamases with E- test and double disc potentiation method. J Antimicrob Chemother, 46: 323-42.
27. Thomson KS (2001). Controversies about extended- spectrum and AmpC β-lactamases. Emerg Infect Dis, 7(2): 333-6.